If you missed the early fall push for flu and COVID-19 vaccines, it's not too late. Health officials say it's important to ...
The booster shot – called mRNA-1273.211 – offered better and longer-lasting protection compared to the original SpikeVax shot against all SARS-CoV-2 variants, including the prevailing Omicron ...
Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...
1 than the original Spikevax. The 437-patient study – reported in June – compared a 50 µg booster dose of both vaccines on antibody levels one month after administration, with the new version ...
Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...
These mRNA vaccines use genetic instructions ... from 19 individuals over 28 days after receiving a Moderna SPIKEVAX mRNA booster immunisation. The team discovered key insights into the movement ...
Fewer health care workers are getting the most recent COVID-19 booster. Findings from a new survey by the ... On top of this, ...
You can get a COVID-19 booster shot when it's been at least six months since ... Children older than six months can get a Moderna Spikevax vaccine, however, not all pharmacies will give it to a child ...
The Massachusetts-based company said that third-quarter revenue from its Spikevax shot came in at $1.8 billion, with $1.2 billion of the sales coming in the United States. The overall figure ...
Moderna (MRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Tyler Van Buren ...
Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...
Analysts had expected a loss of US$753 million, or US$1.90 a share, according to LSEG data. Its Spikevax Covid vaccine brought in sales of US$1.8 billion, up 3.5 per cent over the previous year and ...